Highly selective glycosylated prodrugs of cytostatic CC-1065 analogues for antibody-directed enzyme tumor therapy

ChemBioChem

Volumn 2, Issue 10, 2001, Pages 758-765

  Tietze, Lutz F ^a   Herzig, Tobias ^a   Fecher, Anja ^a   Haunert, Frank ^a   Schuberth, Ingrid ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; DNA; ENZYME; INDOLE DERIVATIVE; KITASAMYCIN DERIVATIVE; PRODRUG; RACHELMYCIN;

ALKYLATION; ARTICLE; CELL CULTURE; CELL DIVISION; CHEMISTRY; DOSE RESPONSE; DRUG DESIGN; DRUG EFFECT; ENZYME SPECIFICITY; GLYCOSYLATION; HUMAN; IMMUNOLOGY; MASS SPECTROMETRY; METABOLISM; NEOPLASM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS;

ALKYLATION; ANTIBIOTICS, ANTINEOPLASTIC; ANTIBODIES; ANTINEOPLASTIC AGENTS; CELL DIVISION; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; ENZYMES; GLYCOSYLATION; HUMANS; INDOLES; LEUCOMYCINS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; NEOPLASMS; PRODRUGS; SUBSTRATE SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0035495592     PISSN: 14394227     EISSN: None     Source Type: Journal    
DOI: 10.1002/1439-7633(20011001)2:10<758::AID-CBIC758>3.0.CO;2-G     Document Type: Article

References (5)

1. a) I. F. Tannock, D. Rotin, Cancer Res. 1989, 49, 4373-4384;
2. b) L. F. Tietze, M. Neumann, T. Möllers, R. Fischer, K.-H. Glüsenkamp, M. F. Rajewsky, E. Jähde, Cancer Res. 1989, 49, 4179-4184;
3. L. F. Tietze, M. Beller, R. Fischer, M. Lögers, E. Jähde, K.-H. Glüsenkamp, M. F. Rajewsky, Angew. Chem. 1990, 102, 812-813;
4. Angew. Chem. Int. Ed. Engl. 1990, 29, 782-783.
5. G. M. Dubowchik, M. A. Walker, Pharmacol. Ther. 1999, 83, 67-123.